Tempest Therapeutics, Inc.
TPST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001544227
No open-market purchases or sales by Tempest Therapeutics, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q3 2026, worth $682.2K in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Tempest Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- −6 vs. Q1 2025
- Shares held
- 944.6K
- +484.0K (+105.1%) vs. Q1 2025Converted for a 1-for-13 split
- Total value
- $6.42M
- +$2.00M (+45.4%) vs. Q1 2025
- New holders
- 3
- 4 more added
- Sold out
- 9
- 7 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TPST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q3 2026 | 23 | $682.2K |
| Q2 2026 | 21 | $1.44M |
| Q1 2026 | 22 | $1.29M |
| Q4 2025 | 21 | $2.26M |
| Q3 2025 | 17 | $6.02M |
| Q2 2025 | 18 | $6.42M |
| Q1 2025 | 24 | $4.42M |
| Q4 2024 | 35 | $5.66M |
| Q3 2024 | 28 | $3.94M |
| Q2 2024 | 24 | $4.70M |
| Q1 2024 | 30 | $7.29M |
| Q4 2023 | 32 | $9.74M |
| Q3 2023 | 24 | $1.05M |
| Q2 2023 | 22 | $4.86M |
| Q1 2023 | 17 | $7.21M |
| Q4 2022 | 13 | $3.54M |
| Q3 2022 | 16 | $5.36M |
| Q2 2022 | 16 | $6.67M |
| Q1 2022 | 15 | $7.12M |
| Q4 2021 | 19 | $12.4M |
| Q3 2021 | 22 | $31.8M |
| Q2 2021 | 24 | $20.5M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Tempest Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sabby Management, LLC | 276,587 | $1.88M | 14.47% | +276,587 | New |
| Versant Venture Management, LLC | 269,772 | $1.83M | 2.23% | 00.0% | UnchangedConverted for a 1-for-13 split |
| Tang Capital Management LLC | 138,962 | $944.9K | 0.05% | +138,962 | New |
| Vanguard Group Inc | 134,608 | $915.3K | 0.00% | +111,694+487.5% | AddedConverted for a 1-for-13 split |
| BlackRock, Inc. | 39,068 | $265.7K | 0.00% | −4,125−9.5% | ReducedConverted for a 1-for-13 split |
| Geode Capital Management, LLC | 34,736 | $236.2K | 0.00% | +1,402+4.2% | AddedConverted for a 1-for-13 split |
| FMR LLC | 33,225 | $225.9K | 0.00% | 00.0% | UnchangedConverted for a 1-for-13 split |
| UBS Group AG | 11,223 | $76.3K | 0.00% | −13,677−54.9% | ReducedConverted for a 1-for-13 split |
| Morgan Stanley | 2,107 | $14.3K | 0.00% | −1,313−38.4% | ReducedConverted for a 1-for-13 split |
| Advisor Group Holdings, Inc. | 1,834 | $12.5K | 0.00% | −145−7.3% | ReducedConverted for a 1-for-13 split |
| National Bank of Canada | 1,538 | $10.4K | 0.00% | 00.0% | UnchangedConverted for a 1-for-13 split |
| Federation des caisses Desjardins du Quebec | 292 | $1.99K | 0.00% | 00.0% | UnchangedConverted for a 1-for-13 split |
| CIBC Private Wealth Group, LLC | 260 | $1.77K | 0.00% | +250+2,441.4% | AddedConverted for a 1-for-13 split |
| Raymond James Financial Inc | 234 | $1.59K | 0.00% | +234 | New |
| SBI Securities Co., Ltd. | 56 | $381 | 0.00% | −3−5.1% | ReducedConverted for a 1-for-13 split |
| Bank of America Corp | 33 | $225 | 0.00% | +6+22.9% | AddedConverted for a 1-for-13 split |
| Parallel Advisors, LLC | 18 | $122 | 0.00% | −0−0.8% | ReducedConverted for a 1-for-13 split |
| BNP Paribas Arbitrage, SA | 3 | $20 | 0.00% | −1−18.7% | ReducedConverted for a 1-for-13 split |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −8,812−100.0% | Sold outConverted for a 1-for-13 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −7,645−100.0% | Sold outConverted for a 1-for-13 split |
| Davenport & Co LLC | 0 | $0 | 0.00% | −3,846−100.0% | Sold outConverted for a 1-for-13 split |
| State Street Corp | 0 | $0 | 0.00% | −3,192−100.0% | Sold outConverted for a 1-for-13 split |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,571−100.0% | Sold outConverted for a 1-for-13 split |
| MayTech Global Investments, LLC | 0 | $0 | 0.00% | −769−100.0% | Sold outConverted for a 1-for-13 split |
| Millstone Evans Group, LLC | 0 | $0 | 0.00% | −62−100.0% | Sold outConverted for a 1-for-13 split |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −6−100.0% | Sold outConverted for a 1-for-13 split |
| Royal Bank of Canada | 0 | $0 | 0.00% | −0−100.0% | Sold outConverted for a 1-for-13 split |